Literature DB >> 36178556

Integrating Gender-Based Violence Screening and Support into the Research Clinic Setting: Experiences from an HIV Prevention Open-Label Extension Trial in Sub-Saharan Africa.

Morgan Garcia1,2, Sarah T Roberts3, Ashley J Mayo4, Rachel Scheckter4, Leila E Mansoor5, Thesla Palanee-Phillips6,7, Krishnaveni Reddy6, Yuthika Naidoo6, Carolyne Agwau Akello8, Zakir Gaffoor9, Samantha Siva9, Chenai Rushwaya10, Kudzai Hlahla10, Jane Jambaya10, Rujeko Makoni10, Evans Kachale11, Margret Ndovie12, Jabulisile Zuma13, Elizabeth T Montgomery3.   

Abstract

HIV and gender-based violence (GBV) are syndemic in sub-Saharan Africa and provision of support for participants who disclose GBV constitutes part of comprehensive care. Consequently, a process was undertaken to develop, implement, and evaluate standard operating procedures (SOPs) in MTN-025/HOPE, a study of the dapivirine vaginal ring for HIV prevention. The SOP was developed using needs assessment surveys in addition to World Health Organization (WHO) guidelines and other literature. Sites tailored and implemented the SOP through HOPE implementation. At study end, staff reported increased training 32/35 (91.43%); improved confidence (18/26; 69.23%); and improved vicarious trauma prevention onsite (17/28; 60.71%). Leadership reported increased staff competence in GBV response. Obstacles included limited referral organizations and time for follow-up, continued training needs, and cultural norms. Development and implementation of an SOP is a feasible strategy to build a GBV response to improve health systems and support sustained effective use of HIV prevention products.
© 2022. The Author(s).

Entities:  

Keywords:  Dapivirine vaginal ring; Gender-based violence response; HIV prevention; Referral networks; Vicarious trauma

Year:  2022        PMID: 36178556     DOI: 10.1007/s10461-022-03864-6

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  1 in total

1.  Does the Ring Work? Perceptions and Understanding of the Efficacy of a Dapivirine Vaginal Ring for HIV Prevention Amongst Women in a Placebo-Controlled Trial.

Authors:  Juliane Etima; Ariana W K Katz; Zoe Duby; Morgan Garcia; Thesla Palanee-Phillips; Krishnaveni Reddy; Florence Mathebula; Chifundo Zimba; Leila E Mansoor; Devika Singh; Elmah Manengamambo; Sarita Naidoo; Lydia Soto-Torres; Elizabeth T Montgomery
Journal:  AIDS Behav       Date:  2021-11-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.